Vitamin D and Type 2 Diabetes - a Cross Sectional Study
|ClinicalTrials.gov Identifier: NCT00695474|
Recruitment Status : Completed
First Posted : June 11, 2008
Last Update Posted : July 14, 2009
|Condition or disease|
|Hypovitaminosis D Type 2 Diabetes Mellitus|
It has been estimated that 1 billion people worldwide have vitamin D deficiency or insufficiency. It is well known that vitamin D deficiency causes osteoporosis, increases the risk of fracture and causes muscle weakness. But there is now evidence that calcium malnutrition and hypovitaminosis D are predisposing conditions for various common chronic diseases such as malignancies (particularly colon, breast and prostate) chronic inflammatory and autoimmune disease (inflammatory bowel disease, multiple sclerosis) as well as metabolic disorders (metabolic syndrome, hypertension).
It has also been reported that vitamin D deficiency may predispose to glucose intolerance, altered insulin secretion and type 2 diabetes mellitus.
The purpose of this study is to determine vitamin D status among type 2 diabetics in our outpatient clinic and examine the relationship between vitamin D status , calcium and phosphorous metabolism, inflammatory markers, glycemic control, blood pressure and lipid profile.
Moreover the patients are asked to answer a questionnaire regarding lifestyle, exercise, sun exposure and food intake.
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Vitamin D and Type 2 Diabetes - a Cross Sectional Study|
|Study Start Date :||June 2008|
|Actual Primary Completion Date :||April 2009|
|Actual Study Completion Date :||April 2009|
U.S. FDA Resources
The cohort consists of type 2 diabetics from the outpatient clinic at Silkeborg Hospital.
- Vitamin D status and its association with inflammation, glycemic control, lipids and blood pressure. [ Time Frame: December 08 ]
- Lifestyle (exercise, sun exposure, food intake) [ Time Frame: December 08 ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00695474
|Principal Investigator:||Lotte Oeskov, MD||Medical Department, Silkeborg Hospital, Falkevej 1-3, 8600 Silkeborg, Denmark|